Promega, NF1001, NanoBRET® TE Intracellular Kinase Assays

Name: NanoBRET® TE Intracellular Kinase Assays
Brand: Promega
SKU: NF1001

Catalog Number: NF1001

Pricing

Send an RFQ.

View RFQ List

Category

Phosphatases & Kinases

TagsCell Signaling Kinase Target Engagement

Description

Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement
Extracellular techniques to measuring binding of kinase inhibitors can fail to accurately predict intracellular target engagement. In this article, published in Cell Chemical Biology , we report the application of an energy transfer technique that enables the first equilibrium-based approach to quantitatively profile target occupancy and compound affinity in live cells.
Discovery of a Selective Inhibitor of Doublecortin-Like Kinase 1
Doublecortin-like kinase 1 (DCLK1) is an understudied kinase that is upregulated in a wide range of cancers, including pancreatic ductal adenocarcinoma (PDAC). This study uses NanoBRET® technology to understand the function of DCLK1 in PDAC cells.
Quantifying CDK Inhibitor Selectivity in Live Cells
Teams at the Structural Genomics Consortium and Promega used the NanoBRET® Target Engagement technology to uncover surprising patterns of selectivity for touted CDKIs and abandoned clinical leads. The results offer exciting opportunities for repurposing some inhibitors as selective chemical probes for lesser-studied CDK family members.
View more publications featuring NanoBRET® TE technology

Specifications

General

Catalog Number	NF1001

Ordering

Notice

Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:

[email protected]

Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.